Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT00710580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis
Study identification
- NCT ID
- NCT00710580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2008 (Type not available)
- Primary completion
- Apr 2009 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Jan 18, 2013
2008 – 2009
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 9984 | Birmingham | Alabama | 35205 | — |
| Site Reference ID/Investigator# 10605 | Birmingham | Alabama | 35233 | — |
| Site Reference ID/Investigator# 10001 | Scottsdale | Arizona | 85251 | — |
| Site Reference ID/Investigator# 10502 | Little Rock | Arkansas | 72205 | — |
| Site Reference ID/Investigator# 9985 | Bakersfield | California | 93309 | — |
| Site Reference ID/Investigator# 10661 | Irvine | California | 92697 | — |
| Site Reference ID/Investigator# 14701 | Los Angeles | California | 90045 | — |
| Site Reference ID/Investigator# 9785 | San Diego | California | 92123 | — |
| Site Reference ID/Investigator# 10662 | Santa Monica | California | 90404 | — |
| Site Reference ID/Investigator# 10642 | Vallejo | California | 94589 | — |
| Site Reference ID/Investigator# 10263 | New Haven | Connecticut | 06511 | — |
| Site Reference ID/Investigator# 10503 | Jacksonville | Florida | 32204 | — |
| Site Reference ID/Investigator# 10266 | Miami | Florida | 33144 | — |
| Site Reference ID/Investigator# 9901 | Miami | Florida | 33173 | — |
| Site Reference ID/Investigator# 10501 | West Palm Beach | Florida | 33407 | — |
| Site Reference ID/Investigator# 15201 | Alpharetta | Georgia | 30022 | — |
| Site Reference ID/Investigator# 10762 | Atlanta | Georgia | 30327 | — |
| Site Reference ID/Investigator# 10262 | Newnan | Georgia | 30263 | — |
| Site Reference ID/Investigator# 9789 | Snellville | Georgia | 30078 | — |
| Site Reference ID/Investigator# 10666 | Maywood | Illinois | 60153 | — |
| Site Reference ID/Investigator# 15142 | Plainfield | Indiana | 46168 | — |
| Site Reference ID/Investigator# 10265 | Louisville | Kentucky | 40202 | — |
| Site Reference ID/Investigator# 15750 | Owensboro | Kentucky | 42303 | — |
| Site Reference ID/Investigator# 9790 | Owensboro | Kentucky | 42303 | — |
| Site Reference ID/Investigator# 9788 | Fort Gratiot | Michigan | 48059 | — |
| Site Reference ID/Investigator# 10604 | Grand Blanc | Michigan | 48439 | — |
| Site Reference ID/Investigator# 10541 | Fridley | Minnesota | 55432 | — |
| Site Reference ID/Investigator# 10641 | St Louis | Missouri | 63110 | — |
| Site Reference ID/Investigator# 10606 | Omaha | Nebraska | 68131 | — |
| Site Reference ID/Investigator# 10644 | Omaha | Nebraska | 68144 | — |
| Site Reference ID/Investigator# 9786 | Berlin | New Jersey | 08009 | — |
| Site Reference ID/Investigator# 10241 | New York | New York | 10016 | — |
| Site Reference ID/Investigator# 9787 | Rochester | New York | 14623 | — |
| Site Reference ID/Investigator# 9902 | Hickory | North Carolina | 28601 | — |
| Site Reference ID/Investigator# 10581 | Wilmington | North Carolina | 28401 | — |
| Site Reference ID/Investigator# 10504 | Dayton | Ohio | 45408 | — |
| Site Reference ID/Investigator# 10643 | Knoxville | Tennessee | 37934 | — |
| Site Reference ID/Investigator# 9981 | Dallas | Texas | 75230 | — |
| Site Reference ID/Investigator# 10264 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 9982 | Webster | Texas | 77598 | — |
| Site Reference ID/Investigator# 10182 | Seattle | Washington | 98101 | — |
| Site Reference ID/Investigator# 10321 | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00710580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2013 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00710580 live on ClinicalTrials.gov.